abstract |
HYBRID ANTI-INFLAMMATORY AGENT, PHARMACEUTICAL COMPOSITION, HYBRID ARTI-INFLAMMATORY AGENT PREPARATION PROCESS AND USE OF THE HYBRID ANTI-INFLAMMATORY AGENT. The present invention is related to hybrid anti-inflammatory agents of cationic lipid and anti-inflammatory drugs, quickly and easily obtained, for applications in the pharmaceutical, medical-hospital, veterinary, biotechnological, oncological, biomedical or preventive areas. |